Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 22 |
NetGPI | no | yes: 0, no: 22 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 3 |
GO:0043226 | organelle | 2 | 3 |
GO:0043227 | membrane-bounded organelle | 3 | 3 |
GO:0043229 | intracellular organelle | 3 | 3 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: Q4QBT2
Term | Name | Level | Count |
---|---|---|---|
GO:0000959 | mitochondrial RNA metabolic process | 6 | 3 |
GO:0000963 | mitochondrial RNA processing | 6 | 3 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 3 |
GO:0006396 | RNA processing | 6 | 3 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 3 |
GO:0006807 | nitrogen compound metabolic process | 2 | 3 |
GO:0008152 | metabolic process | 1 | 3 |
GO:0009987 | cellular process | 1 | 3 |
GO:0010467 | gene expression | 4 | 3 |
GO:0016070 | RNA metabolic process | 5 | 3 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 3 |
GO:0043170 | macromolecule metabolic process | 3 | 3 |
GO:0044237 | cellular metabolic process | 2 | 3 |
GO:0044238 | primary metabolic process | 2 | 3 |
GO:0046483 | heterocycle metabolic process | 3 | 3 |
GO:0071704 | organic substance metabolic process | 2 | 3 |
GO:0090304 | nucleic acid metabolic process | 4 | 3 |
GO:0140053 | mitochondrial gene expression | 5 | 3 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 3 |
GO:0009451 | RNA modification | 5 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0016556 | mRNA modification | 6 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 3 |
GO:0003723 | RNA binding | 4 | 3 |
GO:0003729 | mRNA binding | 5 | 3 |
GO:0005488 | binding | 1 | 3 |
GO:0097159 | organic cyclic compound binding | 2 | 3 |
GO:1901363 | heterocyclic compound binding | 2 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 209 | 213 | PF00656 | 0.536 |
CLV_NRD_NRD_1 | 105 | 107 | PF00675 | 0.526 |
CLV_PCSK_KEX2_1 | 105 | 107 | PF00082 | 0.577 |
CLV_PCSK_KEX2_1 | 316 | 318 | PF00082 | 0.436 |
CLV_PCSK_KEX2_1 | 424 | 426 | PF00082 | 0.373 |
CLV_PCSK_PC1ET2_1 | 316 | 318 | PF00082 | 0.435 |
CLV_PCSK_PC1ET2_1 | 424 | 426 | PF00082 | 0.326 |
CLV_PCSK_SKI1_1 | 16 | 20 | PF00082 | 0.694 |
CLV_PCSK_SKI1_1 | 247 | 251 | PF00082 | 0.433 |
CLV_PCSK_SKI1_1 | 316 | 320 | PF00082 | 0.517 |
CLV_PCSK_SKI1_1 | 356 | 360 | PF00082 | 0.362 |
CLV_PCSK_SKI1_1 | 57 | 61 | PF00082 | 0.500 |
CLV_PCSK_SKI1_1 | 84 | 88 | PF00082 | 0.549 |
DEG_APCC_DBOX_1 | 424 | 432 | PF00400 | 0.403 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.470 |
DOC_CDC14_PxL_1 | 485 | 493 | PF14671 | 0.457 |
DOC_CKS1_1 | 249 | 254 | PF01111 | 0.388 |
DOC_CYCLIN_RxL_1 | 244 | 251 | PF00134 | 0.381 |
DOC_CYCLIN_yCln2_LP_2 | 249 | 255 | PF00134 | 0.388 |
DOC_MAPK_gen_1 | 316 | 326 | PF00069 | 0.393 |
DOC_MAPK_gen_1 | 421 | 431 | PF00069 | 0.385 |
DOC_MAPK_MEF2A_6 | 236 | 245 | PF00069 | 0.477 |
DOC_MAPK_MEF2A_6 | 317 | 326 | PF00069 | 0.391 |
DOC_MAPK_MEF2A_6 | 424 | 431 | PF00069 | 0.386 |
DOC_MAPK_MEF2A_6 | 439 | 448 | PF00069 | 0.321 |
DOC_MAPK_MEF2A_6 | 46 | 54 | PF00069 | 0.575 |
DOC_PP1_RVXF_1 | 221 | 228 | PF00149 | 0.409 |
DOC_USP7_MATH_1 | 186 | 190 | PF00917 | 0.528 |
DOC_USP7_MATH_1 | 260 | 264 | PF00917 | 0.412 |
DOC_USP7_MATH_1 | 363 | 367 | PF00917 | 0.583 |
DOC_USP7_MATH_1 | 53 | 57 | PF00917 | 0.549 |
DOC_WW_Pin1_4 | 248 | 253 | PF00397 | 0.424 |
LIG_14-3-3_CanoR_1 | 190 | 200 | PF00244 | 0.459 |
LIG_14-3-3_CanoR_1 | 308 | 312 | PF00244 | 0.489 |
LIG_14-3-3_CanoR_1 | 33 | 42 | PF00244 | 0.660 |
LIG_14-3-3_CanoR_1 | 7 | 11 | PF00244 | 0.756 |
LIG_BIR_III_4 | 212 | 216 | PF00653 | 0.546 |
LIG_deltaCOP1_diTrp_1 | 338 | 346 | PF00928 | 0.494 |
LIG_deltaCOP1_diTrp_1 | 64 | 70 | PF00928 | 0.463 |
LIG_FHA_1 | 121 | 127 | PF00498 | 0.473 |
LIG_FHA_1 | 240 | 246 | PF00498 | 0.476 |
LIG_FHA_1 | 43 | 49 | PF00498 | 0.728 |
LIG_FHA_1 | 491 | 497 | PF00498 | 0.519 |
LIG_FHA_1 | 56 | 62 | PF00498 | 0.661 |
LIG_FHA_2 | 148 | 154 | PF00498 | 0.517 |
LIG_FHA_2 | 346 | 352 | PF00498 | 0.511 |
LIG_FHA_2 | 39 | 45 | PF00498 | 0.589 |
LIG_LIR_Gen_1 | 219 | 229 | PF02991 | 0.368 |
LIG_LIR_Gen_1 | 274 | 284 | PF02991 | 0.466 |
LIG_LIR_Gen_1 | 338 | 346 | PF02991 | 0.365 |
LIG_LIR_Gen_1 | 371 | 381 | PF02991 | 0.426 |
LIG_LIR_Gen_1 | 405 | 416 | PF02991 | 0.410 |
LIG_LIR_Nem_3 | 193 | 199 | PF02991 | 0.456 |
LIG_LIR_Nem_3 | 219 | 224 | PF02991 | 0.414 |
LIG_LIR_Nem_3 | 274 | 280 | PF02991 | 0.484 |
LIG_LIR_Nem_3 | 297 | 303 | PF02991 | 0.395 |
LIG_LIR_Nem_3 | 338 | 342 | PF02991 | 0.398 |
LIG_LIR_Nem_3 | 371 | 376 | PF02991 | 0.474 |
LIG_LIR_Nem_3 | 405 | 411 | PF02991 | 0.390 |
LIG_NRBOX | 472 | 478 | PF00104 | 0.332 |
LIG_SH2_CRK | 221 | 225 | PF00017 | 0.375 |
LIG_SH2_CRK | 373 | 377 | PF00017 | 0.420 |
LIG_SH2_NCK_1 | 373 | 377 | PF00017 | 0.407 |
LIG_SH2_SRC | 110 | 113 | PF00017 | 0.486 |
LIG_SH2_SRC | 63 | 66 | PF00017 | 0.413 |
LIG_SH2_STAP1 | 221 | 225 | PF00017 | 0.427 |
LIG_SH2_STAP1 | 277 | 281 | PF00017 | 0.395 |
LIG_SH2_STAP1 | 63 | 67 | PF00017 | 0.554 |
LIG_SH2_STAT3 | 265 | 268 | PF00017 | 0.402 |
LIG_SH2_STAT5 | 110 | 113 | PF00017 | 0.480 |
LIG_SH2_STAT5 | 206 | 209 | PF00017 | 0.496 |
LIG_SH2_STAT5 | 265 | 268 | PF00017 | 0.430 |
LIG_SH2_STAT5 | 277 | 280 | PF00017 | 0.444 |
LIG_SH2_STAT5 | 373 | 376 | PF00017 | 0.474 |
LIG_SH2_STAT5 | 399 | 402 | PF00017 | 0.386 |
LIG_SH3_3 | 146 | 152 | PF00018 | 0.540 |
LIG_SH3_3 | 194 | 200 | PF00018 | 0.482 |
LIG_SH3_3 | 347 | 353 | PF00018 | 0.553 |
LIG_SH3_3 | 386 | 392 | PF00018 | 0.440 |
LIG_SH3_3 | 443 | 449 | PF00018 | 0.393 |
LIG_SUMO_SIM_anti_2 | 320 | 326 | PF11976 | 0.503 |
LIG_SUMO_SIM_par_1 | 377 | 385 | PF11976 | 0.525 |
LIG_SUMO_SIM_par_1 | 427 | 437 | PF11976 | 0.452 |
LIG_SUMO_SIM_par_1 | 465 | 472 | PF11976 | 0.470 |
LIG_TYR_ITIM | 61 | 66 | PF00017 | 0.561 |
LIG_TYR_ITSM | 217 | 224 | PF00017 | 0.367 |
MOD_CK1_1 | 113 | 119 | PF00069 | 0.542 |
MOD_CK1_1 | 263 | 269 | PF00069 | 0.403 |
MOD_CK1_1 | 451 | 457 | PF00069 | 0.641 |
MOD_CK1_1 | 55 | 61 | PF00069 | 0.579 |
MOD_CK1_1 | 9 | 15 | PF00069 | 0.753 |
MOD_CK2_1 | 147 | 153 | PF00069 | 0.612 |
MOD_CK2_1 | 179 | 185 | PF00069 | 0.577 |
MOD_CK2_1 | 345 | 351 | PF00069 | 0.507 |
MOD_CK2_1 | 398 | 404 | PF00069 | 0.379 |
MOD_CMANNOS | 67 | 70 | PF00535 | 0.409 |
MOD_GlcNHglycan | 115 | 118 | PF01048 | 0.575 |
MOD_GlcNHglycan | 193 | 196 | PF01048 | 0.580 |
MOD_GlcNHglycan | 2 | 5 | PF01048 | 0.520 |
MOD_GlcNHglycan | 262 | 265 | PF01048 | 0.508 |
MOD_GlcNHglycan | 285 | 288 | PF01048 | 0.487 |
MOD_GlcNHglycan | 365 | 368 | PF01048 | 0.564 |
MOD_GlcNHglycan | 450 | 453 | PF01048 | 0.579 |
MOD_GSK3_1 | 186 | 193 | PF00069 | 0.420 |
MOD_GSK3_1 | 200 | 207 | PF00069 | 0.423 |
MOD_GSK3_1 | 271 | 278 | PF00069 | 0.421 |
MOD_GSK3_1 | 34 | 41 | PF00069 | 0.624 |
MOD_GSK3_1 | 341 | 348 | PF00069 | 0.381 |
MOD_GSK3_1 | 398 | 405 | PF00069 | 0.391 |
MOD_GSK3_1 | 444 | 451 | PF00069 | 0.536 |
MOD_GSK3_1 | 467 | 474 | PF00069 | 0.495 |
MOD_GSK3_1 | 492 | 499 | PF00069 | 0.650 |
MOD_GSK3_1 | 6 | 13 | PF00069 | 0.647 |
MOD_N-GLC_1 | 191 | 196 | PF02516 | 0.456 |
MOD_N-GLC_1 | 402 | 407 | PF02516 | 0.513 |
MOD_NEK2_1 | 10 | 15 | PF00069 | 0.734 |
MOD_NEK2_1 | 177 | 182 | PF00069 | 0.443 |
MOD_NEK2_1 | 271 | 276 | PF00069 | 0.485 |
MOD_NEK2_1 | 28 | 33 | PF00069 | 0.708 |
MOD_NEK2_1 | 358 | 363 | PF00069 | 0.391 |
MOD_NEK2_1 | 444 | 449 | PF00069 | 0.360 |
MOD_PIKK_1 | 147 | 153 | PF00454 | 0.595 |
MOD_PKA_2 | 219 | 225 | PF00069 | 0.378 |
MOD_PKA_2 | 307 | 313 | PF00069 | 0.480 |
MOD_PKA_2 | 34 | 40 | PF00069 | 0.516 |
MOD_PKA_2 | 369 | 375 | PF00069 | 0.490 |
MOD_PKA_2 | 420 | 426 | PF00069 | 0.487 |
MOD_PKA_2 | 6 | 12 | PF00069 | 0.756 |
MOD_PKB_1 | 33 | 41 | PF00069 | 0.476 |
MOD_Plk_1 | 191 | 197 | PF00069 | 0.489 |
MOD_Plk_1 | 239 | 245 | PF00069 | 0.470 |
MOD_Plk_1 | 471 | 477 | PF00069 | 0.343 |
MOD_Plk_4 | 275 | 281 | PF00069 | 0.384 |
MOD_Plk_4 | 472 | 478 | PF00069 | 0.498 |
MOD_ProDKin_1 | 248 | 254 | PF00069 | 0.416 |
MOD_SUMO_for_1 | 330 | 333 | PF00179 | 0.372 |
MOD_SUMO_for_1 | 61 | 64 | PF00179 | 0.586 |
TRG_DiLeu_BaEn_1 | 244 | 249 | PF01217 | 0.486 |
TRG_DiLeu_BaEn_1 | 393 | 398 | PF01217 | 0.419 |
TRG_DiLeu_BaEn_1 | 472 | 477 | PF01217 | 0.337 |
TRG_DiLeu_BaEn_4 | 435 | 441 | PF01217 | 0.458 |
TRG_DiLeu_BaEn_4 | 64 | 70 | PF01217 | 0.404 |
TRG_DiLeu_BaLyEn_6 | 424 | 429 | PF01217 | 0.383 |
TRG_ENDOCYTIC_2 | 221 | 224 | PF00928 | 0.381 |
TRG_ENDOCYTIC_2 | 277 | 280 | PF00928 | 0.392 |
TRG_ENDOCYTIC_2 | 373 | 376 | PF00928 | 0.550 |
TRG_ENDOCYTIC_2 | 63 | 66 | PF00928 | 0.558 |
TRG_ER_diArg_1 | 104 | 106 | PF00400 | 0.549 |
TRG_ER_diArg_1 | 359 | 362 | PF00400 | 0.385 |
TRG_Pf-PMV_PEXEL_1 | 46 | 51 | PF00026 | 0.482 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IK37 | Leptomonas seymouri | 73% | 100% |
A0A0N1IKX3 | Leptomonas seymouri | 28% | 92% |
A0A0S4IN88 | Bodo saltans | 44% | 93% |
A0A0S4JQR1 | Bodo saltans | 30% | 93% |
A0A1X0NRA1 | Trypanosomatidae | 28% | 98% |
A0A1X0NTQ0 | Trypanosomatidae | 57% | 100% |
A0A3Q8II17 | Leishmania donovani | 28% | 100% |
A0A3S7WX47 | Leishmania donovani | 95% | 100% |
A0A422NDT8 | Trypanosoma rangeli | 57% | 100% |
A0A422NKD3 | Trypanosoma rangeli | 28% | 100% |
A4HCA9 | Leishmania braziliensis | 87% | 100% |
A4HLY4 | Leishmania braziliensis | 29% | 100% |
A4HZU2 | Leishmania infantum | 95% | 100% |
A4I9B3 | Leishmania infantum | 28% | 100% |
C9ZJB1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 100% |
C9ZRN1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 58% | 100% |
E9AVP7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
E9B4B3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
Q4Q3R2 | Leishmania major | 28% | 100% |
V5BAI0 | Trypanosoma cruzi | 28% | 100% |
V5BVS4 | Trypanosoma cruzi | 56% | 100% |